What should Canadian investors know about JNJ tax treatment?

JNJ's Kenvue spin-off in 2023 changed the portfolio; plan around post-spin JNJ metrics and verify the current dividend payout ratio for the reorganized pharmaceutical/medtech business.

Is JNJ suitable for a TFSA or RRSP in Canada?

RRSP placement shelters U.S. withholding tax; TFSA and non-registered accounts incur the 15% withholding.

How should I research Johnson & Johnson before adding it to a dividend income plan?

USD denomination requires a CAD/USD conversion assumption for Canadian income planning; use quarterly dividends per share and a conservative exchange rate.

Dividend CompanyUnited States

JNJ

Johnson & Johnson

NYSEHealth CarePlain dividend

Research Signals

Payout sustainability

Strong

4d ago

DRIP availability

Available

4d ago

Tax character

Foreign income

4d ago

Distribution history

Multi-decade

4d ago

Structure complexity

Moderate

4d ago

Income trend

Growing

4d ago

Account suitability

RRSP / RRIF optimal

4d ago

Structure Overview

Johnson & Johnson (JNJ) is a Dividend King with over 60 consecutive years of dividend increases, now focused entirely on pharmaceutical and medical device segments following the Kenvue consumer health spin-off. The pharmaceutical focus adds pipeline risk but also higher margin potential compared to consumer-only peers.

Canadian Planning Notes

1JNJ's Kenvue spin-off in 2023 changed the portfolio; plan around post-spin JNJ metrics and verify the current dividend payout ratio for the reorganized pharmaceutical/medtech business.
2RRSP placement shelters U.S. withholding tax; TFSA and non-registered accounts incur the 15% withholding.
3USD denomination requires a CAD/USD conversion assumption for Canadian income planning; use quarterly dividends per share and a conservative exchange rate.

Live Data (On Demand)

Yahoo Finance Fact Card

Load live price, dividend yield, and payout data on demand.

Live data from Yahoo Finance. Always verify with the issuer before making any decision.

Run Your Numbers

Use Prospyr's planning tools to model this holding's income timing, DRIP durability, payout structure, and tax treatment before including it in a plan.

Run dividend calculation

Related Holdings

ABBV

AbbVie

Quarterly

ABT

Abbott Laboratories

Quarterly

AMGN

Amgen

Quarterly

XIU.TO

iShares S&P/TSX 60 Index ETF

Quarterly

BNS.TO

Bank of Nova Scotia

Quarterly

This profile is informational only and does not constitute licensed financial advice. Signal values, planning notes, and structure summaries are editorial and may not reflect the most current issuer disclosures. Always verify current payout policy, ex-dividend dates, financial statements, and issuer communications before making any investment decision.